Detalhe da pesquisa
1.
Optima TB: A tool to help optimally allocate tuberculosis spending.
PLoS Comput Biol
; 17(9): e1009255, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34570767
2.
Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors.
Bull World Health Organ
; 91(1): 36-45, 2013 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23397349
3.
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.
Eur Respir J
; 39(6): 1425-31, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22005924
4.
Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience.
Eur Respir J
; 49(3)2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28331042
5.
Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory.
Tuberc Res Treat
; 2021: 6646239, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33868727
6.
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study.
BMJ Open
; 10(6): e035350, 2020 06 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32554740
7.
Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis.
Int J Mycobacteriol
; 5 Suppl 1: S23, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28043573
8.
Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis.
J Clin Tuberc Other Mycobact Dis
; 4: 21-27, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27284577
9.
Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors
Bull. W.H.O. (Print)
; 91(1): 36-45, 2013-1-01.
Artigo
Inglês
| WHOLIS | ID: who-271238